A new kind of medical eye drops have been submitted for approval to the American FDA which have the potential to help users read without glasses.
The drug, a pilocarpine solution, works by treating the symptoms of presbyopia, also known as near-sightedness, a condition that becomes worse as people age. Presbyopia is caused by hardening of the lens, which loses the elasticity it needs to focus from far-off objects to closer ones.
Two randomized trials of 750 patients has found the drug to be safe and effective, in general increasing the ability of the people to read by up to three lines in low light. The drops begin working 15 minutes after they are used but reach peak performance after an hour.
If approved, the drops will become the first treatment for presbyopia.
Body of child Sarim, missing for 11 days, found in N. Karachi
- ایک گھنٹہ قبل
There’s a very popular explanation for Trump’s win. It’s wrong.
- 7 گھنٹے قبل
Various cities including Punjab engulfed in dense fog
- 4 گھنٹے قبل
IHC judges' roster for next week released
- 2 گھنٹے قبل
Nov 26 protest: Decision reserved on post-arrest bail appeals of PTI suspects
- 4 گھنٹے قبل
23-year-old Indian actor dies in road accident
- 4 گھنٹے قبل
Truth behind terrorist organization BLA’s brutal attack revealed
- 5 منٹ قبل
Japanese Ambassador, Maryam Nawaz agree to promote investment
- 3 گھنٹے قبل
Pakistani mountaineer Asad Ali climbs Antarctica’s highest peak
- 3 گھنٹے قبل
Israeli cabinet approves Gaza ceasefire accord
- ایک گھنٹہ قبل
The public’s fixation on celebrity wildfire victims has an unexpected benefit
- 7 گھنٹے قبل
NADRA’s new service in Karachi to facilitate citizens
- 2 گھنٹے قبل
